Cybin (HELP) Other Non Operating Income (2020 - 2026)
Cybin (HELP) posted quarterly Other Non Operating Income of $1.7 million for Q1 2026, down 88.79% year-on-year from $15.1 million in Q1 2025, and up 9888.24% on a QoQ basis from $17000.0 in Q4 2025.
Cybin (HELP) Other Non Operating Income (2020 - 2026) Analysis & Trends
Cybin (HELP) has reported Other Non Operating Income for 7 consecutive years, with $1.7 million the latest figure, recorded in Q1 2026.
- Quarterly Other Non Operating Income fell 88.79% year-over-year to $1.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.9 million (down 89.39% YoY) and the FY2026 annual result came in at $492000.0, down 96.84% from the prior year.
- Other Non Operating Income improved to $1.7 million in Q1 2026 per HELP's latest filing, from $17000.0 in the prior quarter.
- Over the last five years, Other Non Operating Income for HELP reached as high as $15.1 million in Q1 2025 and fell as low as -$1.8 million in Q2 2022.
- A 5-year average of $1.5 million and a median of $1468.0 in 2023 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2022 — Other Non Operating Income surged 1557536.06% — and 2024, when it sank 100781.8%.
- Year by year, Other Non Operating Income stood at $996759.1 in 2022, then sank by 100.25% to -$2531.9 in 2023, then surged by 541344.21% to $13.7 million in 2024, then sank by 99.88% to $17000.0 in 2025, then jumped by 9888.24% to $1.7 million in 2026.
- According to Business Quant data, Other Non Operating Income over the past three periods registered $1.7 million, $17000.0, and -$755000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Cybin | 28.04 Mn | 28.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.70 Mn |
| Dec 31, 2025 | 17,000.00 |
| Sep 30, 2025 | -755,000.00 |
| Jun 30, 2025 | 1.94 Mn |
| Mar 31, 2025 | 15.14 Mn |
| Dec 31, 2024 | 13.70 Mn |
| Sep 30, 2024 | -1.48 Mn |
| Jun 30, 2024 | 3,352.00 |
| Mar 31, 2024 | -1.74 Mn |
| Dec 31, 2023 | -2,531.94 |
| Sep 30, 2023 | 1,467.99 |
| Jun 30, 2023 | -1.41 Mn |
| Feb 28, 2023 | -1.40 Mn |
| Dec 31, 2022 | 996,759.08 |
| Sep 30, 2022 | 2,189.00 |
| May 31, 2022 | -1.77 Mn |
| Mar 31, 2022 | -351.00 |
| Dec 31, 2021 | -64.00 |
| Sep 30, 2021 | -150,937.77 |
| Jun 30, 2021 | 25,219.34 |